Dr. Matthew Scott Painschab, MD

Dr. Painschab practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Painschab's NPI, 1245593474, was assigned on June 22, 2012. Dr. Painschab holds North Carolina license 2016-00511.

Dr. Painschab's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Painschab's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Painschab to 2 more medical groups, 1 behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Painschab practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Painschab's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Painschab's licenses on file in 2 states: North Carolina and Illinois.

CMS data shows 84 Medicare services from Dr. Painschab across 2 procedure codes in 2024, for 24 Medicare patients. Medicare paid $7,853 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 24 Medicare patients who saw Dr. Painschab in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Painschab's median patient age at 60, with 39% women.

In 2019, Dr. Painschab wrote 11 Medicare Part D claims. They cover 1 drug, with $6,414 in total drug cost. In 2017, CMS named 13 claims across 1 drug.

Dr. Painschab accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 24 papers to Dr. Painschab, published from 2018 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Malawi, HIV Infections and Antineoplastic Combined Chemotherapy Protocols. Dr. Painschab has published most often in JCO Glob Oncol. Dr. Painschab's most frequent co-authors are Satish Gopal, MD, Gita Suneja, MD and Nader Kim El-Mallawany, MD.

CMS Open Payments shows 2 general payments to Dr. Painschab from 2 drug and device companies from 2019 to 2024. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 76% of the total. Bristol-Myers Squibb Company paid the most, $380.